Are you one of many people suffering from kidney disease?
Reports say that patients with kidney failure suffer from a lot of negative side effects such as low appetite, nausea, vomiting, and weight loss. Because of this, many opt for treatment that’ll benefit their overall health.
Are you weighing the Ultomiris vs Soliris debate when choosing your kidney treatment? There’s a lot to consider when making a decision. Between their prices and side effects, it can be a little overwhelming.
Don’t worry; we’ve got you covered. Here’s a guide to Ultomiris and Soliris, helping you make a decision that’s right for you. Read along to learn more!
Definition of Ultomiris and Soliris
Ultomiris (ravulizumab-cwvz) and Soliris (eculizumab) are two therapies used to treat a rare blood disorder called atypical hemolytic uremic syndrome. Both drugs work by blocking a protein in the blood called C5. By doing this, they help to prevent the destruction of the red blood cells that are often seen in patients with this disorder.
Patients may be prescribed Ultomiris or Soliris depending on a number of factors, including age, previous treatment, symptoms, and persons’ lifestyle. Both drugs have the ability to be very effective, but they can also be very expensive for some patients. Finally, each patient’s individual health situation should be discussed with a doctor in order to determine which treatment is best for them.
Which Is the Best?
Both prescription medications have been approved by the FDA. The main difference between Ultomiris and Soliris comes down to the dosing schedule. Ultomiris is taken every eight weeks whereas Soliris requires dosing every two weeks.
In terms of effectiveness, both types of medications are relatively comparable. Therefore, which one is best may come down to personal preference and convenience. Finally, the decision should be decided by your doctor who is familiar with your medical history and needs.
Cost
Soliris and Ultomiris both fall into the classification of medicines known as specialty drugs. This means that they treat rare, but potentially life-threatening, medical conditions. It is important to note that the cost of either drug can vary from patient to patient, but typically speaking, Soliris costs less than Ultomiris does.
The average cost for Soliris is around $450,000 for a year’s worth of treatment, while the average cost for Ultomiris is up to $540,000 for a year’s worth of treatment. With the cost difference being significant, it is not a surprise that many choose Soliris, even though Ultomiris is newer and reported to be more effective.
Finally, the decision of which discounted medication to choose depends on the patient’s individual needs and the cost associated with each treatment.
Pick the Best Between Ultomiris vs Soliris Today
Due to its longer half-life, Ultomiris has the potential to create more flexible treatment schedules for individuals with PNH and aHUS. Finally, the choice of therapy is up to the doctor and the individual. Be sure to talk to your doctor about the treatment option if Ultomiris vs Soliris is best for you.
